Abstract:Several therapeutic regimens have been proposed for women with recurrent spontaneous abortion (RSA) and antiphospholipid antibodies (APA). Conflicting results have been reported about women with history of RSA, positive APA, and failure of standard therapy. To evaluate the use of intravenous immunoglobulin in RSA patients with APA and history of treatment failure, we initiated a study with standard therapy (aspirin and low-molecular- weight heparin) and intravenous immunoglobulin. We used an enzyme-linked immunosorbent assay (ELISA)test to screen IgG and IgM anticardiolipin antibodies, and a diluted Russel viper venom time assay for the lupus anticoagulant activity. Altogether. 66 pregnant women with positive APAs at the first visit could be included. Patients with hereditable thrainbaghilic factors were excluded. After confirmation of the pregnancy, women received a basis immunization of 0.3 g/kg immunoglobulin in a 4-week cycle until the 28th to 32nd week of gestation. All patients received 100 mg/d aspirin and 3,000 anti-Xa U/d certoparin. Among the 66 pregnant women, 17 were persistently autoantibody positive (25.8%), of whom 11 (16.7%) were ACA positive alone, 2 (3%) were lupus anticoagulant positive, and 4 (6.4%) had both antibody types. A total of 49 patients had positive APAs at the initial test, but were negative for ACA and lupus anticoagulant at the second test administered approximately 5 weeks after the start of therapy. We described this group in our following observation as "antibody negative." Sixteen of the 17 autoantibody-positive patients (94.1 %) were delivered of live infants compared with 40 patients (81.6%) in the antibody-negative group (odds ratio [OR]: 1.2; 95% CI: 0.98 to 1.4). The overall miscarriage rate was 12.1% and the fetal loss rate was 15.2%. Four patients (25%) in the antibody-positive group developed symptoms of preeclampsia and fetal growth retardation compared with four patients (9.8%) in the antibody-negative group. In conclusion. we see a reduction of the fetal loss rate in patients with RSA and positive APA (5.8%) compared with APAnegative (18.4%) women with the same therapy (OR: 0.3; 95% CI: 0.04 to 2.3).

Impact of Anticardiolipin Antibody on the Outcome of in Vitro Fertilization and Embryo Transfer

Research Progress on the Relationship between Anticardiolipin Antibodies and Adverse Pregnancy Outcomes

A Retrospective Study on IVF Outcome in Patients with Anticardiolipin Antibody: Effects of Methylprednisolone Plus Low-Dose Aspirin Adjuvant Treatment.

Effect of Immunoantibodies on Outcome of IVF-ET

The Association of ACA on Embryonic Development and Pregnancy Outcomes in Patients Undergoing IVF/ICSI Treatment

Effect of Antithyroid Antibodies in the First Trimester on Pregnancy Outcomes

Preliminary Investigation of the Impact of Anticentromere Antibody on Oocyte Maturation and Embryo Cleavage

IVF/ICSI Outcomes of Euthyroid Infertile Women with Thyroid Autoimmunity: Does Treatment with Aspirin Plus Prednisone Matter?

Relationship Between Serum Antisperm Antibodies and Anticardiolipin Antibodies and Clinical Pregnancy Outcome in an in Vitro Fertilization and Embryo Transfer Program.

Relationship Between Antithyroid Antibody And Pregnancy Outcome Following In Vitro Fertilization And Embryo Transfer

Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes

Effect of Aspirin Combined with Prednisone on Pregnancy Outcome in People with Positive Anti Phospholipid Antibody Undergoing IVF-ET

Anticentromere antibodies are the most potent antinuclear antibodies in reducing live birth outcomes after ICSI

Negative Association between Thyroid Autoimmunity and High Miscarriage Rate In Vitro Fertilization and Embryo Transfer

The Influence of Antiphospholipid Antibodies on the Pregnancy Outcome of Patients With Recurrent Spontaneous Abortion

A further exploration of the impact of antinuclear antibodies on in vitro fertilization-embryo transfer outcome.

Serum antiphospholipid antibody status may not be associated with the pregnancy outcomes of patients undergoing in vitro fertilization

Antinuclear antibodies predicts a poor IVF-ET outcome: impaired egg and embryo development and reduced pregnancy rate.

Impact of Thyroid Cancer Treatment on Assisted Reproductive Technology Outcomes in Women with Infertility

The application of individualised immune-suppression and anticoagulant in therapy of RSA with ACA.

Clinical Significance of Anticardiolipin Antibody Detected in Umbilical Blood